Impact on Xerostomia for Nasopharyngeal Carcinoma Patients Treated With or Without Superficial Parotid Lobe-sparing Intensity-modulated Radiotherapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a prospective phase II clinical randomized controlled study, the purpose of this study is to assess whether superficial parotid lobe-sparing intensity-modulated radiotherapy (SPLS-IMRT) can decrease the incidence of xerostomia versus conventional IMRT (C-IMRT) in NPC patients.
Epistemonikos ID: c8fb51a1c8a41bdbdadca340c4572c9851700387
First added on: May 09, 2024